Brief: Kaisa Health Group Says Qinghai Pharmaceutical Obtains NMPA Drug Registration
27/07/2026 16:45
BRIEF-Kaisa Health Group Says Qinghai Pharmaceutical Obtains NMPA Drug Registration July 27 (Reuters) - Kaisa Health Group Holdings Ltd 0876.HK:
QINGHAI PHARMACEUTICAL OBTAINS NMPA DRUG REGISTRATION FOR HYDROMORPHONE HYDROCHLORIDE INJECTION ON JULY 21, 2026
Further company coverage: 0876.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kaisa Health group
See all newsBrief: Kaisa Health Group Expects HY Loss Attributable Of Not More Than HK$65.0 MLN
Brief: Kaisa Health Group Says Qinghai Pharmaceutical Obtains NMPA Drug Registration
Brief: Kaisa Health Group Liu Lihao Resigns As Executive Director
Brief: Kaisa Health Proposes Share Consolidation
Brief: Kaisa Announces Disposal Of 30.1210% Effective Interest In Project Co